Focus Stocks
Devon Energy Closing in to Resistance
Published on Thursday, 09 February 2012 07:40 Written by TradersHuddle Wire
New York, February 9th (TradersHuddle.com) - Shares of Devon Energy Corporation (NYSE:DVN) are trading very close to calculated resistance at $66.61 with the current price action closing at just $66.26 placing the stock near levels that make it difficult to buy.
Devon Energy Corporation (NYSE:DVN) is an independent energy company that is involved primarily in oil and gas exploration, development and production, the transportation of oil, gas, and NGLs and the processing of natural gas.
Devon's current stock range is defined by current calculated support defined at $62.81 and by the resistance level at $66.61, the stock is clearly over-extended from support, making it difficult to establishing new long positions at this level.
Traders don't have a clear entry point for Devon Energy, as the stock is well above support, however, as the stock pulls back towards $62.81 it will definitely provide a reference point to establish a trade. On the other hand if the stock decides to break above resistance level at $66.61 then traders will get an opportunity to enter Devon Energy stock by establishing a position as the stock moves to a higher range.
Related Articles
- Up/Downgrades
- Devon Energy Announces Upcoming Investor Event
- Trading Idea: What to Expect with Devon Energy Breaking Support
- Devon Energy Is Approaching its 200 Day Moving Average
- Trading Idea: Is Devon Energy close to Support?
- Is Devon Energy Resistance Ahead?
- Trading Idea: - Is Devon Energy close to Resistance?
- Devon Energy Earns $393 Million in First-Quarter 2012; Oil Production Increases 26 Percent
- Critical Alerts For Time Warner, eBay, Lincoln National, Kohls, and Devon Energy Released By InvestorsObserver
- Devon Energy Is in a Well Defined Range
Related Partner Headlines
- Devon Energy Corp (DVN): Today's Featured Basic Materials Loser - TheStreet.com
- Analysts' Actions: DVN, EOG, LOW - TheStreet.com
- Buying Into Earnings Disappointments - TheStreet.com
- Pritchard Capital Partners Initiates Coverage on Devon Energy - Benzinga
- Devon Energy Corp (DVN): Today's Featured Basic Materials Loser - TheStreet.com
- UPDATE: Guggenheim Lowers Devon Energy's PT - Benzinga
- President Should Go Local with Energy - TheStreet.com
- Devon Energy Stock To Go Ex-dividend Tomorrow (DVN) - TheStreet.com
- UPDATE: Oppenheimer Raises Target to $90 on Devon Energy Corporation - Benzinga
- As Gasoline Rises, Buy ... Nat-Gas Stocks? - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
The Dow Bounces on Test of 12,312 - TheStreet.com -
Coming Week: Top Nine Earnings on Deck - TheStreet.com -
For Ambitious Students, Entrepreneurship Can Be a Big Win - TheStreet.com -
Something's Not Right in the Video-Game Space - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
Vertex Receives European CHMP Positive Opinion for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis -
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus









